Pendyala G, Calvo-Calle J, Moreno A, Kane R
Bioeng Transl Med. 2023; 8(4):e10514.
PMID: 37476056
PMC: 10354751.
DOI: 10.1002/btm2.10514.
Markwalter C, Petersen J, Zeno E, Sumner K, Freedman E, Mangeni J
PLoS Pathog. 2023; 19(6):e1011442.
PMID: 37307293
PMC: 10289385.
DOI: 10.1371/journal.ppat.1011442.
Markwalter C, Petersen J, Zeno E, Sumner K, Freedman E, Mangeni J
medRxiv. 2023; .
PMID: 36711685
PMC: 9882554.
DOI: 10.1101/2023.01.04.23284198.
Huang W, Mabrouk M, Zhou L, Baba M, Tachibana M, Torii M
Commun Biol. 2022; 5(1):773.
PMID: 35915227
PMC: 9341416.
DOI: 10.1038/s42003-022-03688-z.
Espinosa D, Christensen D, Munoz C, Singh S, Locke E, Andersen P
NPJ Vaccines. 2017; 2.
PMID: 28936360
PMC: 5603302.
DOI: 10.1038/s41541-017-0011-y.
Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine.
Collins K, Snaith R, Cottingham M, Gilbert S, Hill A
Sci Rep. 2017; 7:46621.
PMID: 28422178
PMC: 5395940.
DOI: 10.1038/srep46621.
Protection against malaria by PfSPZ Vaccine.
Epstein J, Paolino K, Richie T, Sedegah M, Singer A, Ruben A
JCI Insight. 2017; 2(1):e89154.
PMID: 28097230
PMC: 5214067.
DOI: 10.1172/jci.insight.89154.
Defining rules of CD8(+) T cell expansion against pre-erythrocytic Plasmodium antigens in sporozoite-immunized mice.
Billman Z, Kas A, Stone B, Murphy S
Malar J. 2016; 15:238.
PMID: 27113469
PMC: 4845300.
DOI: 10.1186/s12936-016-1295-5.
Complex Minigene Library Vaccination for Discovery of Pre-Erythrocytic Plasmodium T Cell Antigens.
Stone B, Kas A, Billman Z, Fuller D, Fuller J, Shendure J
PLoS One. 2016; 11(4):e0153449.
PMID: 27070430
PMC: 4829254.
DOI: 10.1371/journal.pone.0153449.
Short-lived effector CD8 T cells induced by genetically attenuated malaria parasite vaccination express CD11c.
Cooney L, Gupta M, Thomas S, Mikolajczak S, Choi K, Gibson C
Infect Immun. 2013; 81(11):4171-81.
PMID: 23980113
PMC: 3811835.
DOI: 10.1128/IAI.00871-13.
A T-cell response to a liver-stage Plasmodium antigen is not boosted by repeated sporozoite immunizations.
Murphy S, Kas A, Stone B, Bevan M
Proc Natl Acad Sci U S A. 2013; 110(15):6055-60.
PMID: 23530242
PMC: 3625320.
DOI: 10.1073/pnas.1303834110.
Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA.
Richie T, Charoenvit Y, Wang R, Epstein J, Hedstrom R, Kumar S
Hum Vaccin Immunother. 2012; 8(11):1564-84.
PMID: 23151451
PMC: 3601132.
DOI: 10.4161/hv.22129.
Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults.
Dodoo D, Hollingdale M, Anum D, Koram K, Gyan B, Akanmori B
Malar J. 2011; 10:168.
PMID: 21689436
PMC: 3132199.
DOI: 10.1186/1475-2875-10-168.
Strain-specific immunity induced by immunization with pre-erythrocytic stages of Plasmodium chabaudi.
Culleton R, Inoue M, Reece S, Cheesman S, Carter R
Parasite Immunol. 2010; 33(1):73-8.
PMID: 21189655
PMC: 3937739.
DOI: 10.1111/j.1365-3024.2010.01251.x.
Advances and challenges in malaria vaccine development.
Crompton P, Pierce S, Miller L
J Clin Invest. 2010; 120(12):4168-78.
PMID: 21123952
PMC: 2994342.
DOI: 10.1172/JCI44423.
Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate.
Plassmeyer M, Reiter K, Shimp Jr R, Kotova S, Smith P, Hurt D
J Biol Chem. 2009; 284(39):26951-63.
PMID: 19633296
PMC: 2785382.
DOI: 10.1074/jbc.M109.013706.
Molecular cloning and sequencing of the circumsporozoite protein gene from Plasmodium falciparum strain FCC-1/HN and expression of the gene in Mycobacteria.
Zheng C, Xie P, Chen Y
J Clin Microbiol. 2001; 39(8):2911-5.
PMID: 11474012
PMC: 88259.
DOI: 10.1128/JCM.39.8.2911-2915.2001.
Role of cysteines in Plasmodium falciparum circumsporozoite protein: interactions with heparin can rejuvenate inactive protein mutants.
Rathore D, McCutchan T
Proc Natl Acad Sci U S A. 2000; 97(15):8530-5.
PMID: 10890903
PMC: 26982.
DOI: 10.1073/pnas.140224597.
The cytotoxic T-lymphocyte epitope of the Plasmodium falciparum circumsporozoite protein also modulates the efficiency of receptor-ligand interaction with hepatocytes.
Rathore D, McCutchan T
Infect Immun. 2000; 68(2):740-3.
PMID: 10639441
PMC: 97200.
DOI: 10.1128/IAI.68.2.740-743.2000.
Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine.
Shi Y, Hasnain S, Sacci J, Holloway B, Fujioka H, Kumar N
Proc Natl Acad Sci U S A. 1999; 96(4):1615-20.
PMID: 9990073
PMC: 15536.
DOI: 10.1073/pnas.96.4.1615.